8.8: Erythrocytes

Essentials of Physiology for Nurse Anesthetists (Gopalan) · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY-NC-SA 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    8.8: Erythrocytes

    Erythrocytes, also known as RBCs, are the most abundant formed elements in the blood. A mere drop of blood contains millions of erythrocytes along with thousands of leukocytes. Males typically have around 5.4 million erythrocytes per microliter (µL) of blood, while females have approximately 4.8 million per µL. Erythrocytes make up roughly 25 percent of the total body cells. They are small in size, with an average diameter of only about 7–8 micrometers (µm).  

    The primary functions of erythrocytes are twofold: they bind to inhaled oxygen in the lungs and transport it to all tissues, and they carry carbon dioxide waste from the tissues back to the lungs for exhalation. Unlike leukocytes, which often leave the bloodstream to perform their defensive duties, erythrocytes remain confined within the vascular network.

    During the maturation process in the red bone marrow, erythrocytes undergo significant changes. They expel their nucleus and most other organelles to make room for the accumulation of hemoglobin within their cytoplasm. In the first day or two after entering circulation, immature erythrocytes, known as reticulocytes, may still contain remnants of organelles. Reticulocytes typically constitute around 1–2 percent of the total erythrocyte count and serve as a rough indicator of the rate of RBC production. Abnormally low or high reticulocyte counts can signify deviations in erythrocyte production. However, these remnants of organelles are swiftly shed, leaving circulating mature erythrocytes with minimal internal cellular structures. Erythrocytes are devoid of mitochondria and primarily rely on anaerobic respiration, meaning they do not utilize the oxygen they transport. They also lack endoplasmic reticula and do not engage in protein synthesis. Nonetheless, erythrocytes do contain specific structural proteins that help maintain their unique shape and enable them to alter their form to navigate through capillaries.

    Erythrocytes exhibit a distinctive biconcave disc shape characterized by a plump periphery and a thin center (Figure 4). This unique morphology arises from their lack of most organelles, including a nucleus, which creates more space to accommodate hemoglobin molecules responsible for gas transport. The biconcave design offers several advantages in facilitating gas exchange. Firstly, it provides an expanded surface area relative to its volume, enhancing the efficiency of gas exchange. In contrast, a sphere with a similar diameter would have a lower surface area-to-volume ratio. Within capillaries, erythrocytes carry oxygen that can readily diffuse into the surrounding plasma and subsequently traverse the capillary walls to reach nearby cells. Simultaneously, some of the carbon dioxide generated as a waste product by these cells diffuses into the capillaries to be absorbed by the erythrocytes.

    Capillary beds, where much of this gas exchange occurs, are exceedingly narrow. This narrowness slows the movement of erythrocytes through the capillaries, prolonging the window for efficient gas exchange. However, the confines of capillaries can be so compact that even erythrocytes, despite their small size, may need to flex and fold to navigate through. Fortunately, the flexible structural proteins in erythrocytes allow them to bend considerably, effectively accommodating these tight spaces. Subsequently, when they enter wider blood vessels, erythrocytes may stack upon one another, akin to a roll of coins, forming a structure known as rouleaux, derived from the French word for "roll."1

    A close-up illustration of red blood cells flowing through a blood vessel with a red and pink textured background.
    Figure 4 | Normal Erythrocyte Morphology | 7 This image illustrates the typical biconcave shape and uniform size of healthy red blood cells within a blood vessel.

    Hemoglobin

    Illustration of hemoglobin molecule on the left, showing polypeptide chains with labeled ions. Chemical structure diagram on the right details molecular composition and bonds.
    Figure 5 | Structure of Hemoglobin | 8  (a) Hemoglobin contains four globin proteins, each of which is bound to one molecule of the iron-containing pigment, heme. (b) Heme with its porphyrin ring containing iron (\(\ce{Fe2+}\)) in the center.  ​

    Hemoglobin represents a substantial molecular complex composed of proteins and iron. It comprises four intricately folded protein chains known as globin, designated explicitly as alpha 1, alpha 2, beta 1, and beta 2 (Figure 5a). Each globin subunit is associated with a red pigment molecule called heme, which houses an iron ion (Figure 5b). The iron ions within the heme possess the remarkable capacity to bind with oxygen molecules. Consequently, each hemoglobin molecule can engage with four oxygen molecules simultaneously. Within an individual erythrocyte, there exists a vast quantity of approximately 300 million hemoglobin molecules, implying the potential to capture and transport a staggering 1.2 billion oxygen molecules (Figure 5b).

    Within the pulmonary environment, hemoglobin undergoes oxygenation by acquiring oxygen, forming a compound known as oxyhemoglobin. This brightly colored, oxygen-saturated hemoglobin then journeys to various body tissues, gradually relinquishing some of its oxygen molecules. As it does so, it transforms into a darker red substance called deoxyhemoglobin, sometimes denoted as reduced hemoglobin. The extent of oxygen release hinges upon the local demand within the surrounding tissues. Under normal resting conditions, approximately 25 percent of the oxygen molecules carried by hemoglobin are discharged. Hemoglobin rarely, if ever, surrenders all of its oxygen content. Simultaneously, in the body's capillaries, carbon dioxide enters the bloodstream. Roughly 7 percent of it dissolves within the plasma, while a portion remains as dissolved carbon dioxide. The remaining fraction combines with amino acids within hemoglobin to form carbaminohemoglobin, encompassing approximately 23–24 percent of the total carbon dioxide content.

    Upon traversing the capillaries, hemoglobin transports carbon dioxide back to the lungs, where it is released to enable the exchange of oxygen. Deviations in RBC levels can significantly impact the body's capacity to deliver oxygen to tissues effectively. Ineffective hematopoiesis, for instance, results in inadequate RBC numbers and, consequently, reduced hemoglobin availability. This condition may lead to insufficient oxygen delivery to tissues, resulting in various forms of anemia. Conversely, excessive RBC production gives rise to a condition termed polycythemia. While polycythemia does not directly impede oxygen delivery to tissues, it increases blood viscosity, making it more challenging for the heart to circulate blood effectively.

    Tissue oxygenation can be assessed through a parameter known as percent saturation, which denotes the percentage of hemoglobin binding sites occupied by oxygen. Monitoring this parameter is typically accomplished using a pulse oximeter, which is usually applied to a slender body part, such as the tip of a patient's finger. Normal readings obtained from a pulse oximeter typically fall within the 95–100 percent range. Lower percentages indicate a condition known as hypoxemia, signifying diminished blood oxygen levels. The broader term hypoxia encompasses situations characterized by reduced oxygen concentrations. Alternatively, free oxygen within the plasma is directly monitored, often through arterial blood sampling. In this context, the quantity of oxygen is expressed in terms of partial pressure of oxygen, abbreviated as pO2, and is conventionally measured in millimeters of mercury (mm Hg).

    The kidneys play a pivotal role in this process as they filter approximately 180 liters of blood per day in an average adult. Consequently, the kidneys serve as ideal locations for receptors that gauge oxygen saturation. In response to hypoxemia, wherein diminished oxygen levels are detected, less oxygen exits the blood vessels that supply the kidneys. This results in hypoxia within the kidney tissue fluid, where actual oxygen concentrations are monitored. Specialized interstitial fibroblasts within the kidneys respond to hypoxia by secreting EPO, thereby stimulating the production of erythrocytes to restore oxygen levels to a normal range. This process operates within a classic negative feedback loop: as oxygen saturation levels rise, EPO secretion diminishes, and conversely, when oxygen levels decline, EPO production increases. Consequently, this negative feedback loop plays a vital role in preserving homeostasis.

    Populations residing at high altitudes, where the atmosphere inherently contains lower oxygen levels, naturally maintain a higher hematocrit than individuals living at sea level. Consequently, individuals traveling to elevated regions may experience symptoms of hypoxemia, such as fatigue, headaches, and shortness of breath, for a few days following their arrival. In response to hypoxemia, the kidneys initiate the secretion of EPO, leading to an elevation in erythrocyte counts until homeostasis is reestablished.1 

    Life Cycle of Erythrocytes

    Erythrocyte production within the bone marrow occurs at a remarkable rate, surpassing 2 million cells per second. This prolific production necessitates the availability of several essential raw materials, which are fundamental to the production and maintenance of any cell, including glucose, lipids, and amino acids. However, erythrocyte production specifically requires various trace elements:

    Iron: Hemoglobin, the molecule responsible for oxygen transport within erythrocytes, contains ferrous ions in each heme group. The body typically absorbs less than 20 percent of dietary iron. Heme iron, derived from animal-based foods like meat, poultry, and fish, is more efficiently absorbed than non-heme iron found in plant-based foods. Iron becomes a part of the body's total iron pool upon absorption. The bone marrow, liver, and spleen can store iron in proteins known as ferritin and hemosiderin. Transferrin facilitates the transfer of iron from storage sites across intestinal cell plasma membranes into tissue fluid, from where it enters the bloodstream. When stimulated by EPO to increase erythrocyte production, iron is released from storage, binds to transferrin, and is transported to the red bone marrow, where it becomes integrated into erythrocyte precursors.

    Copper: Copper, another trace mineral, plays a vital role in two plasma proteins, hephaestin and ceruloplasmin. These proteins are essential for the production of hemoglobin. Hephaestin, located in the intestinal villi, facilitates iron absorption by intestinal cells, while ceruloplasmin transports copper. Copper deficiency can lead to reduced iron transport for heme synthesis, causing iron to accumulate in tissues and potentially resulting in organ damage.

    Zinc: Zinc, a trace mineral, acts as a co-enzyme that assists in the synthesis of the heme portion of hemoglobin.

    B Vitamins: Folate and vitamin B12 function as co-enzymes for DNA synthesis. Consequently, they play a critical role in the production of new cells, including erythrocytes. A deficiency in dietary folate, particularly during early pregnancy, has been linked to neural tube defects in fetal development.

    Erythrocytes have a lifespan of up to 120 days in the bloodstream before they are removed by specialized myeloid phagocytic cells called macrophages, primarily located within the bone marrow, liver, and spleen. The life cycle of erythrocytes is summarized in Figure 6. During the degradation of erythrocytes, the hemoglobin components undergo further processing. Globin, the protein component of hemoglobin, is broken down into amino acids, which can be returned to the bone marrow for use in the production of new erythrocytes. The iron within the heme group is either stored in the liver or spleen, primarily in the form of ferritin or hemosiderin or transported via transferrin in the bloodstream to the red bone marrow for recycling into new erythrocytes. The non-iron portion of heme is metabolized into biliverdin, a green pigment, which is further converted into bilirubin, a yellow pigment, as a waste product. Bilirubin binds to albumin and is transported in the blood to the liver, where it is utilized in bile synthesis. Bile is released into the intestines to aid in the emulsification of dietary fats. In the large intestine, bacteria convert bilirubin into urobilinogen and subsequently into stercobilin, which is excreted in feces. The color changes associated with hemoglobin breakdown pigments can be observed in various scenarios. For instance, biliverdin from damaged erythrocytes contributes to the vivid colors seen in bruises at injury sites. In cases of impaired liver function, ineffective bilirubin removal leads to a yellowish discoloration known as jaundice. Stercobilin within feces impart the typical brown color, while urobilins are responsible for the yellow color observed in urine. Hemoglobin that is not phagocytized undergoes breakdown in the circulation, with the alpha and beta chains being released and subsequently removed from circulation by the kidneys.6

    Flowchart illustrating a medical process with labeled diagrams of the liver, cells, blood vessels, and bone growth, showing stages of disease progression and treatment steps.    

    Figure 6 | Erythrocyte Lifecycle and Hemoglobin Recycling | 9  This figure illustrates the lifecycle of red blood cells (erythrocytes), from their production in the bone marrow to their breakdown and recycling of components. (1) Hemopoiesis: Erythropoiesis, the formation of erythrocytes, begins in the bone marrow. Stem cells differentiate into erythroblasts and then reticulocytes. (2) Circulation: Reticulocytes are released into the bloodstream, where they mature into erythrocytes. (3) Erythrocyte Breakdown: Old or damaged erythrocytes are phagocytized by macrophages in the bone marrow, liver, and spleen. (4) Globin Recycling: Within the macrophage, the globin portion of hemoglobin is broken down into amino acids, which are then reused for protein synthesis. (5) Heme Breakdown and Iron Transport: The heme portion of hemoglobin is broken down into biliverdin, which is transported in the blood. Iron ions are released and bind to the protein transferrin for transport throughout the body. (6) Heme and Iron Recycling/Excretion: Unused heme groups can be recycled and used in hemopoiesis, or converted into bilirubin and processed by the liver to make bile. Iron ions can be stored in the liver bound to ferritin.

     


    This page titled 8.8: Erythrocytes was last modified on Wed, 19 Mar 2025 23:13:00 GMT and is shared under a CC BY-NC-SA 4.0 license and was authored, remixed, and/or curated by Chaya Gopalan (Consortium of Academic and Research Libraries in Illinois (CARLI)) .